Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
Oct 20, 2021
0
6
Using telemedicine, COVID-19 patients can be cared for safely at home—from initial home isolation to recovery or, in case problems arise, admission to hospital. A team from the Technical University of Munich (TUM) has now ...
Oct 7, 2021
0
10
Could living at high altitudes affect your chance of suffering a stroke? This intriguing question is at the heart of a new study in open-access journal Frontiers in Physiology. The study is the first to examine the incidence ...
Sep 30, 2021
0
40
(HealthDay)—If you're older and your legs ache, it could be nothing—or it could be a sign of peripheral artery disease (PAD).
Sep 29, 2021
0
100
Adults who are obese but appear healthy (without common metabolic abnormalities such as high blood pressure, abnormal blood fats, or diabetes) are not at greater risk of heart attack, stroke, or cardiovascular death than ...
Sep 28, 2021
0
33
Specific and dynamic changes on electrocardiograms (EKGs) of hospitalized patients with COVID-19 or influenza can help predict a timeframe for worsening health and death, according to a new Mount Sinai study. The work, published ...
Sep 24, 2021
0
11
As part of the NIH-sponsored ACTIV-2 clinical trial for COVID-19 outpatients, preliminary data revealed that a new combination monoclonal antibody treatment reduced hospitalizations and death by 78 percent in high-risk patients. ...
Sep 1, 2021
0
19
Telemedicine appointments combined with in-person visits significantly reduced the risk of further illness for children with medically complex cases, according to results of a new study by researchers with The University ...
Aug 31, 2021
0
114
In an observational study, Mayo Clinic researchers report that the combination of casirivimab and imdevimab—two monoclonal antibody treatments under Food and Drug Administration emergency use authorization—keep high-risk ...
Aug 30, 2021
0
76
(HealthDay)—For patients undergoing percutaneous coronary intervention, ticagrelor monotherapy following three months of dual antiplatelet therapy significantly reduces clinically relevant bleeding compared with ticagrelor ...
Jul 7, 2021
0
5
